HEALTHMEDPAGE TODAY
FDA Approves New Blood Test for Colon Cancer Screening
The FDA approved SimpleScreen CRC, a blood-based test for colon cancer screening in adults 45 and older at average risk. Freenome announced the approval, which adds to Guardant Health's existing Shield test.
Mentioned
Related Signal
Adjacent reporting
- New blood test is added an an option for colorectal cancer screenings
- Blood test added to colorectal cancer screening options by cancer group
- Blood test added to screening guidelines for colorectal cancers for first time
- Recommending Blood Tests for CRC Without Guardrails Risks Confusion
- Doctors push new blood tests for colon cancer as cases surge in younger adults
- Doctors push new blood tests for colon cancer as cases surge in younger adults